Evaluation of Serum Prestin as a Potential Biomarker for Trauma Severity in Patients with Traumatic Brain Injury

ArticleAçık Erişim

Özet

Objective: Prestin, expressed in cochlear outer hair cells, is essential for auditory signal amplification and may serve as a biomarker for cochlear injury related to trauma. This study aimed to investigate the potential role of prestin in the diagnosis and prognosis of cranial trauma. Methods: A total of 150 participants were included, comprising 110 patients aged 18–70 who were treated for head trauma and 40 age-matched healthy controls. The patients were divided into two groups of 55 each, with Glasgow coma scale (GCS) ≥13 and GCS ≤8, according to the GCS. Prestin was measured by enzyme-linked immunosorbent assay in serum on days 1, 3, and 7 in the patient and also the control groups. In the diagnosis of trauma and determining trauma severity, important risk levels (cut-off values) according to prestin's measurement days were calculated by receiver operating characteristic (ROC) analysis. Results: Prestin values in both the GCS ≥13 and GCS ≤8 groups were dramatically lower than those in the control on all measurement days. Additionally, prestin values in the GCS ≤8 group on days 3 and 7 tended to be lower than those in the GCS ≥13 group. Furthermore, there was a tendency for serum prestin values to increase as time progressed especially in the GCS ≥13 group. ROC analysis showed that prestin values on the first, third, and seventh days showed high accuracy in detecting traumatized individuals with area under the curve (AUC) values of 85%, 81%, and 75%, respectively (sensitivity: 84%, 79%, and 83%, respectively). Also, prestin data on the first day accurately detected the severity of trauma at a high rate (sensitivity, 82%; AUC, 90%). Conclusion: Our findings suggest that serum prestin levels on the first day after trauma may provide supportive information regarding trauma severity. However, further controlled studies are needed before definitive diagnostic or prognostic use. © 2026 The Korean Neurosurgical Society.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/10242Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.3340/jkns.2025.0143Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorYalınkılıç, Abdulaziz
dc.contributor.authorHuyut, Zübeyir
dc.contributor.authorAkyol, Mehmet Edip
dc.contributor.authorGündemir, Damla Ayan
dc.contributor.authorHuyut, Mehmet Tahir
dc.contributor.authorÇetin, Yaser Said
dc.date.accessioned2026-10-18T20:25:29.617809063Z
dc.date.available2026-10-18T20:25:29.617809063Z
dc.date.issued2026
dc.description.abstractObjective: Prestin, expressed in cochlear outer hair cells, is essential for auditory signal amplification and may serve as a biomarker for cochlear injury related to trauma. This study aimed to investigate the potential role of prestin in the diagnosis and prognosis of cranial trauma. Methods: A total of 150 participants were included, comprising 110 patients aged 18–70 who were treated for head trauma and 40 age-matched healthy controls. The patients were divided into two groups of 55 each, with Glasgow coma scale (GCS) ≥13 and GCS ≤8, according to the GCS. Prestin was measured by enzyme-linked immunosorbent assay in serum on days 1, 3, and 7 in the patient and also the control groups. In the diagnosis of trauma and determining trauma severity, important risk levels (cut-off values) according to prestin's measurement days were calculated by receiver operating characteristic (ROC) analysis. Results: Prestin values in both the GCS ≥13 and GCS ≤8 groups were dramatically lower than those in the control on all measurement days. Additionally, prestin values in the GCS ≤8 group on days 3 and 7 tended to be lower than those in the GCS ≥13 group. Furthermore, there was a tendency for serum prestin values to increase as time progressed especially in the GCS ≥13 group. ROC analysis showed that prestin values on the first, third, and seventh days showed high accuracy in detecting traumatized individuals with area under the curve (AUC) values of 85%, 81%, and 75%, respectively (sensitivity: 84%, 79%, and 83%, respectively). Also, prestin data on the first day accurately detected the severity of trauma at a high rate (sensitivity, 82%; AUC, 90%). Conclusion: Our findings suggest that serum prestin levels on the first day after trauma may provide supportive information regarding trauma severity. However, further controlled studies are needed before definitive diagnostic or prognostic use. © 2026 The Korean Neurosurgical Society.
dc.identifier.doi10.3340/jkns.2025.0143
dc.identifier.eissn1598-7876
dc.identifier.endpage195
dc.identifier.issn2005-3711
dc.identifier.issue2
dc.identifier.pmcidPMC12963877
dc.identifier.pmid41121959
dc.identifier.scopus2-s2.0-105031719817
dc.identifier.startpage186
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/10242
dc.identifier.volume69
dc.identifier.wosWOS:001703513000002
dc.language.isoen
dc.publisherKorean Neurosurgical Society
dc.relation.ispartofJournal of Korean Neurosurgical Society
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectCranial trauma
dc.subjectDiagnosis
dc.subjectPrestin
dc.subjectPrognosis
dc.subjectTrauma severity
dc.subjectbiological marker
dc.subjectadult
dc.subjectaged
dc.subjectarea under the curve
dc.subjectArticle
dc.subjectauditory signal amplification
dc.subjectblood biochemistry
dc.subjectclinical assessment
dc.subjectclinical evaluation
dc.subjectcomparative study
dc.subjectcomputer assisted tomography
dc.subjectcontrolled study
dc.subjectcorrelation analysis
dc.subjectdemographics
dc.subjectdemography
dc.subjectdependent variable
dc.subjectdiagnostic accuracy
dc.subjectenzyme linked immunosorbent assay
dc.subjectepidural hematoma
dc.subjectfollow up
dc.subjectGeneralized Estimating Equation
dc.subjectGlasgow coma scale
dc.subjecthomogeneity of group variance
dc.subjecthospitalization
dc.subjecthuman
dc.titleEvaluation of Serum Prestin as a Potential Biomarker for Trauma Severity in Patients with Traumatic Brain Injury
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus0
rdl.citation.wos0
rdl.departmentDepartment of Biostatistics and Medical Informatics, Faculty of Medicine, Erzincan Binali Yildirım University, Erzincan, Turkey.
rdl.oa.statusgold
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)